Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients

被引:62
作者
Kobashigawa, Jon A.
Starling, Randall C.
Mehra, Mandeep R.
Kormos, Robert L.
Bhat, Geetha
Barr, Mark L.
Sigouin, Chris S.
Kolesar, June
Fitzsimmons, William
机构
[1] Univ Calif Los Angeles, Heart Transplant Program, Los Angeles, CA 90095 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[3] Univ Maryland, Baltimore, MD 21201 USA
[4] Univ Pittsburgh, Pittsburgh, PA USA
[5] Univ So Calif, Los Angeles, CA USA
[6] Astellas Pharma Inc, Tokyo, Japan
关键词
D O I
10.1016/j.healun.2006.05.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous risk factor studies in cardiac transplant patients have analyzed pre-transplant risk factors as they relate to outcomes. This study is the first in-depth multicenter assessment of ongoing post-transplant risk factors in heart transplant patients and their impact on 5-year outcomes. Methods: We reviewed 280 heart transplant patients who survived > 1 year for the impact of post-transplant risk factors (hyperhpidemia, hypertension, diabetes, body mass index [BMI] and renal dysfunction: 8 to 18 possible measurements over 5 years) on outcomes, including death, cardiac allograft vasculopathy (CAV) and non-fatal major adverse cardiac events (NF-MACE). Results: Upon multivariate Cox regression analysis, significant findings were high total-cholesterol for NF-MACE (relative risk [RR] = 4.34, confidence interval [CI] 1.35 to 13.98, p = 0.01), presence of diabetes for NF-MACE (RR = 3.96, ci 1.24 to 12.65, P = 0.02) and high serum creatinine for graft death (RR = 1.59, Cl 1.35 to 1.87,p < 0.001). No covariates were found to be significant for CAV. Other significant risk factors by univariate Cox regression models with time-dependent covariates included BMI >= 33 for graft death. Conclusions: Post-transplant risk factors of hypercholesterolemia and diabetes are associated with NF-MACE, whereas high serum creatinine and BMI 33 are associated with graft death. Risk factor modification, including direct therapy to minimize risk factors, should be considered.
引用
收藏
页码:1063 / 1069
页数:7
相关论文
共 32 条
[11]  
Hornick P, 1997, CIRCULATION, V96, P148
[12]   Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus [J].
John, PR ;
Thuluvath, PJ .
LIVER TRANSPLANTATION, 2002, 8 (08) :708-713
[13]   Impact of lipid abnormalities in development and progression of transplant coronary disease: A serial intravascular ultrasound study [J].
Kapadia, SR ;
Nissen, SE ;
Ziada, KN ;
Rincon, G ;
Crows, TD ;
Boparai, N ;
Young, JB ;
Tuzcu, EM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (01) :206-213
[14]  
Kasiske BL, 2000, J AM SOC NEPHROL, V11, P1735, DOI 10.1681/ASN.V1191735
[15]  
Kobashigawa JA, 1995, J HEART LUNG TRANSPL, V14, pS221
[16]   EFFECT OF PRAVASTATIN ON OUTCOMES AFTER CARDIAC TRANSPLANTATION [J].
KOBASHIGAWA, JA ;
KATZNELSON, S ;
LAKS, H ;
JOHNSON, JA ;
YEATMAN, L ;
WANG, XM ;
CHIA, D ;
TERASAKI, PI ;
SABAD, A ;
COGERT, GA ;
TROSIAN, K ;
HAMILTON, MA ;
MORIGUCHI, JD ;
KAWATA, N ;
HAGE, A ;
DRINKWATER, DC ;
STEVENSON, LW .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (10) :621-627
[17]   Statins as a newly recognized type of immunomodulator [J].
Kwak, B ;
Mulhaupt, F ;
Myit, S ;
Mach, F .
NATURE MEDICINE, 2000, 6 (12) :1399-1402
[18]   VASCULAR TISSUE-PLASMINOGEN ACTIVATOR AND THE DEVELOPMENT OF CORONARY-ARTERY DISEASE IN HEART-TRANSPLANT RECIPIENTS [J].
LABARRERE, CA ;
PITTS, D ;
NELSON, DR ;
FAULK, WP .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (17) :1111-1116
[19]   Morbidity and mortality in diabetic patients following cardiac transplantation [J].
Lang, CC ;
Beniaminovitz, A ;
Edwards, N ;
Mancini, DM .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (03) :244-249
[20]   Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation [J].
Lietz, K ;
John, R ;
Burke, EA ;
Ankersmit, JH ;
McCue, JD ;
Naka, Y ;
Oz, MC ;
Mancini, DM ;
Edwards, NM .
TRANSPLANTATION, 2001, 72 (02) :277-283